Skip to content

S. 33 · 118th Congress (2023–2025)

MMEDS Act of 2023

This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical product manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical product manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical product manufacturers..

The bill also directs the Department of Health and Human Services to study the extent to which the health of aging individuals and vulnerable populations have been disproportionately harmed by the COVID-19 (i.e., coronavirus disease 2019) pandemic and prior epidemics and pandemics.

Show official title

A bill to rescue domestic medical product manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 33’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Marco Rubio (R-FL)
Policy area
Taxation
Subjects
  • Aging
  • Business expenses
  • Business investment and capital
  • Cardiovascular and respiratory health
  • Community life and organization
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Economic development
  • 15 more
    • Emergency medical services and trauma care
    • Government studies and investigations
    • Health technology, devices, supplies
    • Income tax credits
    • Income tax deductions
    • Industrial facilities
    • Infectious and parasitic diseases
    • Manufacturing
    • Minority health
    • Public-private cooperation
    • Research administration and funding
    • Research and development
    • Unemployment
    • Veterans' medical care
    • Wages and earnings

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Finance.

    Sources
  3. Expired

    Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.

Committees

  1. SenateFinanceReferred Jan 24, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. MMEDS Act of 2023

    Display title, Short title · Introduced in Senate

  2. Medical Manufacturing, Economic Development, and Sustainability Act of 2023

    Short title · Introduced in Senate

  3. A bill to rescue domestic medical product manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.

    Official title · Introduced in Senate